Inhibrx Biosciences Inc (INBX)
R&D Expenses
$23.90M
Quarterly · Period ending: · USD
INBX R&D Expenses
Latest reported$23.90Mperiod ending
Latest reported$23.90Mperiod ending
INBX Quarterly R&D Expenses ($7.29M → $23.90M)
Quarterly R&D Expenses
High-resolution chart · PNG
INBX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 23,899,000 | |
| 24,687,000 | |
| 25,349,000 | |
| 28,535,000 | |
| 22,267,000 | |
| 36,877,000 | |
| 33,367,000 | |
| 38,233,000 | |
| 67,632,000 | |
| 63,595,000 | |
| 81,839,000 | |
| 38,057,000 | |
| 33,864,000 | |
| 37,149,000 | |
| 30,451,000 | |
| 24,934,000 | |
| 29,906,000 | |
| 24,895,000 | |
| 18,615,000 | |
| 18,485,000 | |
| 17,902,000 | |
| 16,438,000 | |
| 17,668,000 | |
| 19,837,000 | |
| 18,974,000 | |
| 17,016,000 | |
| 12,283,000 | |
| 12,785,000 | |
| 12,174,000 | |
| 10,665,000 | |
| 4,680,000 | |
| 8,495,000 | |
| 10,779,000 | |
| 7,289,000 |